Caughey Elaine 4
4 · Kymera Therapeutics, Inc. · Filed Mar 3, 2022
Insider Transaction Report
Form 4
Caughey Elaine
Chief Business Officer
Transactions
- Award
Common Stock
2022-03-01+7,000→ 7,000 total - Award
Stock Option (Right to Buy)
2022-03-01+41,000→ 41,000 totalExercise: $38.53Exp: 2032-02-29→ Common Stock (41,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in three equal annual installments following March 1, 2022, subject to the reporting person's continued employment through each vesting date.
- [F2]The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following March 1, 2022, subject to the reporting person's continued employment through each vesting date.